Vitiligo, Alopecia Areata May Up Atopic Dermatitis Risk

This article originally appeared here.
Share this content:
Vitiligo, Alopecia Areata May Up Atopic Dermatitis Risk
Vitiligo, Alopecia Areata May Up Atopic Dermatitis Risk

FRIDAY, Dec. 5, 2014 (HealthDay News) -- The prevalence of atopic dermatitis (AD) is higher among patients with vitiligo or alopecia areata (AA), according to research published online Dec. 3 in JAMA Dermatology.

Girish C. Mohan, M.D., and Jonathan I. Silverberg, M.D., Ph.D., M.P.H., of the Northwestern University Feinberg School of Medicine in Chicago, conducted a systematic review of the literature and performed a meta-analysis of data from 33 observational studies. The authors sought to assess the prevalence of AD among patients with and without either vitiligo or AA.

The researchers found that pooled analysis showed significantly increased risk of AD in patients with vitiligo (odds ratio [OR], 7.82; P < 0.001) or AA (OR, 2.57; P < 0.001). Pooled analysis of data from three studies showed greater risk of AD among patients with early-onset vitiligo (less than 12 years) rather than late-onset vitiligo (OR, 3.54; P < 0.001). Pooled analysis of data from four studies showed greater risk of AD among patients with alopecia totalis or alopecia universalis rather than patchy alopecia (OR, 1.22; P = 0.04).

"Patients with either vitiligo, especially early-onset disease, or AA, especially alopecia totalis or alopecia universalis, have significantly increased risk for AD," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Vit D Independently, Inversely Tied to Cholesterol in Children

Vit D Independently, Inversely Tied to Cholesterol in ...

Gene variants do not modify the associations of 25(OH)D with lipids

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound

Weight Gain After Quitting Smoking May Up T2DM Risk

Weight Gain After Quitting Smoking May Up T2DM ...

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »